Disease Landscape and Forecast Insights

Clarivate Epidemiology’s coverage of chronic low back pain (CLBP) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of CLBP for…

Clarivate Epidemiology’s coverage of chronic low back pain (CLBP) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of CLBP for…

Clarivate Epidemiology’s coverage of chronic low back pain (CLBP) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of CLBP for…

Clarivate Epidemiology’s coverage of chronic low back pain (CLBP) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of CLBP for…

Amyotrophic lateral sclerosis (ALS) is a progressively debilitating disorder of the central nervous system characterized by motor neuron degeneration. ALS causes progressive weakness and atrophy of…

Tumor necrosis factor-alpha (TNF-α) inhibitors (e.g., AbbVie’s Humira, Amgen’s Enbrel) and Janssen’s interleukin (IL)-12/23 inhibitor Stelara have been leading the U.S. psoriasis biologics…

KEY BENEFITS AND USES Pinpoint current drug positioning and uptake in one snapshot to facilitate forecasting. Drill down into physicians’ treatment sequences and understand who to…

Clarivate Epidemiology’s coverage of actinic keratosis (AK) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France,…

Since 2018, four novel calcitonin gene-related peptide (CGRP)-targeting monoclonal antibodies (MAbs)—Novartis / Amgen’s Aimovig, Eli Lilly’s Emgality, Teva’s Ajovy, and Lundbeck’s Vyepti…

Clarivate Epidemiology’s coverage of acne comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of acne for each country, as well…

The treatment of chronic pain continues to provide unique challenges to physicians owing to the heterogeneity of pain pathophysiology within and across different chronic pain subtypes and the…

Clarivate Epidemiology’s coverage of asthma comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of asthma for each country, as well…